Science Explorer Back to mapMap

Most cited papers from Bon Secours Health System

What are the most cited papers from Bon Secours Health System?

The most cited paper from Bon Secours Health System is "Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis" (Kris V. Kowdley et al., 2014), with 1,131 citations. Next come "Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options" (1,093) and "Relationship Between Hours of CPAP Use and Achieving Normal Levels of Sleepiness and Daily Functioning" (1,068).

Showing 50 of 61 papers. Every paper with more than 43 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis Kris V. Kowdley et al. · New England Journal of Medicine Open access 11 Apr 2014 1,131
2 Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options Ira M. Jacobson et al. · New England Journal of Medicine Open access 23 Apr 2013 1,093
3 Relationship Between Hours of CPAP Use and Achieving Normal Levels of Sleepiness and Daily Functioning Terri E. Weaver, Greg Maislin, David F. Dinges et al. · SLEEP Open access Jun 2007 1,068
4 Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial Paul David Brown, Shannon K. Pugh, Nadia N. Laack et al. · Neuro-Oncology Open access 16 Aug 2013 963
5 Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial Leonard B. Seeff, Gregory T. Everson, Timothy R.M. Morgan et al. · Clinical Gastroenterology and Hepatology Open access 2 Apr 2010 472
6 A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin Mark G. Swain, Ming–Yang Lai, Mitchell L. Shiffman et al. · Gastroenterology Open access 15 Jul 2010 326
7 The effects of neighborhood conditions on perceptions of safety D. Mark Austin, L. Allen Furr, Michael Spine · Journal of Criminal Justice 26 Aug 2002 275
8 Quality of life in adults with brain tumors: Current knowledge and future directions Raymond Liu, Margaretta Page, Karla N. Solheim et al. · Neuro-Oncology Open access 10 Nov 2008 257
9 Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients Arthur E. Frankel, Jung Hee Woo, Chul Woo Ahn et al. · Blood Open access 24 May 2014 236
10 American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States Jaime Ponce, Eric J. DeMaria, Ninh Tuan Nguyen et al. · Surgery for Obesity and Related Diseases 2 Sep 2016 204
11 Self-Efficacy in Sleep Apnea: Instrument Development and Patient Perceptions of Obstructive Sleep Apnea Risk, Treatment Benefit, and Volition to Use Continuous Positive Airway Pressure Terri E. Weaver, Greg Maislin, David F. Dinges et al. · SLEEP Sep 2003 201
12 Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection Michael Fried, Stephanos J. Hadziyannis, Mitchell L. Shiffman et al. · Journal of Hepatology 24 Nov 2010 192
13 The Ability of 4 Single-Limb Hopping Tests to Detect Functional Performance Deficits in Individuals With Functional Ankle Instability Erin Caffrey, Carrie L. Docherty, John W. Schrader et al. · Journal of Orthopaedic and Sports Physical Therapy 15 Oct 2009 191
14 Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C Mark Sulkowski, Curtis Cooper, Béla Hunyady et al. · Nature Reviews Gastroenterology & Hepatology Review 8 Mar 2011 148
15 Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet Belinda S Lennerz, Anna Beth Barton, Richard K Bernstein et al. · PEDIATRICS Open access 7 May 2018 146
16 Overview of Clinical Decision Support Systems Eta S. Berner, Tonya J. La Lande · Computers in health care Book chapter 2007 133
17 Assessment of age-related decline of neurovascular coupling responses by functional near-infrared spectroscopy (fNIRS) in humans Tamás Csípő, Péter Mukli, Ágnes Lipécz et al. · GeroScience Open access Oct 2019 114
18 Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease Mitchell L. Shiffman, Bradley L. Freilich, Raj Vuppalanchi et al. · Alimentary Pharmacology & Therapeutics Open access 14 Nov 2018 114
19 Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate Mark Sulkowski, Mitchell L. Shiffman, Nezam H. Afdhal et al. · Gastroenterology Open access 17 Aug 2010 113
20 miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer Xiaohui Tan, Jin Peng, Yebo Fu et al. · Breast Cancer Research Open access 17 Sep 2014 113
21 The Molecular Basis of Hereditary Enamel Defects in Humans John Timothy Wright, I.A. Carrion, Clark Morris · Journal of Dental Research Open access 11 Nov 2014 111
22 Use of Procalcitonin in Patients With Various Degrees of Chronic Kidney Disease Including Renal Replacement Therapy Edward E. Grace, Robin M. Turner · Clinical Infectious Diseases Open access 16 Sep 2014 106
23 High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials Patrick Marcellin, Hugo Cheinquer, Manuela Curescu et al. · Hepatology 18 Jun 2012 105
24 miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer Xiaohui Tan, Yebo Fu, Liang Chen et al. · Oncotarget Open access 18 Nov 2015 104
25 Electroconvulsive Therapy: A Selected Review Robert M. Greenberg, Charles H. Kellner · American Journal of Geriatric Psychiatry Apr 2005 103
26 Current Approaches, Challenges and Future Directions for Monitoring Treatment Response in Prostate Cancer Timothy J. Wallace, T. Torre, Mayer B. Grob et al. · Journal of Cancer Open access 2014 96
27 Decreased physical activity among headstart children with a history of wheezing: Use of an accelerometer to measure activity Vincent Firrincieli, Adrienne Keller, Ryan Ehrensberger et al. · Pediatric Pulmonology 27 Apr 2005 93
28 Long‐term clearance of hepatitis C virus following interferon α‐2b or peginterferon α‐2b, alone or in combination with ribavirin Michael Peter Manns et al. · Journal of Viral Hepatitis 3 Mar 2013 87
29 Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C Tariq Ahmad, Philip D. Yin, Jeffrey E. Saffitz et al. · Hepatology 24 Sep 2014 84
30 Age-related impairment of neurovascular coupling responses: a dynamic vessel analysis (DVA)-based approach to measure decreased flicker light stimulus-induced retinal arteriolar dilation in healthy older adults Ágnes Lipécz, Tamás Csípő, Stefano Tarantini et al. · GeroScience Open access Jun 2019 80
31 Psychological Trauma and Substance Abuse: The Need for an Integrated Approach Priscilla Dass-Brailsford, Amie C. Myrick · Trauma Violence & Abuse 7 Sep 2010 79
32 Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment Robert J. Wong, Mamta K. Jain, George Therapondos et al. · The American Journal of Gastroenterology 9 Mar 2018 78
33 Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial Gregory T. Everson, Mitchell L. Shiffman, John Carl Hoefs et al. · Hepatology Open access 26 Oct 2011 78
34 Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell–Cell Contact and Secreted Factors Han-Ching Tseng, Vickie T. Bui, Yan‐Gao Man et al. · Frontiers in Immunology Open access 19 Jun 2014 78
35 Obesity in America Raul Jacobo Rosenthal, John Magaña Morton, Stacy A. Brethauer et al. · Surgery for Obesity and Related Diseases 12 Aug 2017 77
36 2 FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF INT-747 TO URSODEOXYCHOLIC ACID Andrew L. Mason, Velimir A. Luketic, K. Lindor et al. · Journal of Hepatology Apr 2010 77
37 Anorectal Malignant Melanoma: Extensive 45-Year Review and Proposal for a Novel Staging Classification Claudius Falch, Alexander Stojadinovic, Claus Hann-von-Weyhern et al. · Journal of the American College of Surgeons 20 May 2013 70
38 The Chief Clinical Informatics Officer (CCIO) Patricia R Sengstack, Thankam Paul Thyvalikakath, John Poikonen et al. · Applied Clinical Informatics Open access 2016 61
39 Management of hepatitis C virus infection in the Asia-Pacific region: an update Seng Gee Lim, Alessio Aghemo, Pei‐Jer Chen et al. · ˜The œLancet. Gastroenterology & hepatology 10 Dec 2016 60
40 Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag et al. · Hepatology Open access 11 Jan 2011 58
41 Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data Julius M. Wilder, Lennox J. Jeffers, Natarajan Ravendhran et al. · Hepatology Open access 8 Nov 2015 58
42 The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease Nadege Gunn, Mitchell L. Shiffman · Clinics in Liver Disease 9 Nov 2017 57
43 American Society for Metabolic and Bariatric Surgery: care pathway for laparoscopic sleeve gastrectomy Dana Alexa Telem, Jon Charles Gould, Carl M. Pesta et al. · Surgery for Obesity and Related Diseases 24 Jan 2017 56
44 Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response Andrew Joseph Muir, Fred F Poordad, John G. McHutchison et al. · Hepatology Open access 11 Jul 2011 55
45 Physician Referral Patterns and Race Differences in Receipt of Coronary Angiography Thomas A. LaVeist, Athol Morgan, Melanie Arthur et al. · Health Services Research Open access Aug 2002 55
46 Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology Kathleen E. Corey, Joseph Misdraji, Lou Gelrud et al. · Digestive Diseases and Sciences Open access 3 Apr 2015 54
47 Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct‐Acting‐Antiviral Period? Mamta K. Jain, Mae Thamer, George Therapondos et al. · Hepatology 18 Jul 2018 53
48 Nocturia, Sleep and Daytime Function in Stable Heart Failure Nancy Schmieder Redeker, Laura L Adams, Robert L. Berkowitz et al. · Journal of Cardiac Failure Open access 28 Jun 2012 53
49 Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model Guangfu Li, Dai Liu, Timothy K. Cooper et al. · Journal of Hepatology Open access 10 Aug 2016 51
50 Racial differences in hepatitis C treatment eligibility Michael T. Melia, Andrew Joseph Muir, Jonathan McCone et al. · Hepatology Open access 12 Apr 2011 51

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.